Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Aromatase Inhibitors Modify the Gut Microbiome Effecting Estrogen Bioavailability

NCT05030038 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT05030038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05030038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Aromatase Inhibitors Modify the Gut Microbiome Effecting Estrogen Bioavailability
Lead sponsor
Wake Forest University Health Sciences
Phase
Observational
Overall status
Completed
Start date
March 29, 2022
Completion date
July 28, 2025
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer